MA43465B2 - Compositions and methods for treating rheumatoid arthritis - Google Patents

Compositions and methods for treating rheumatoid arthritis

Info

Publication number
MA43465B2
MA43465B2 MA43465A MA43465A MA43465B2 MA 43465 B2 MA43465 B2 MA 43465B2 MA 43465 A MA43465 A MA 43465A MA 43465 A MA43465 A MA 43465A MA 43465 B2 MA43465 B2 MA 43465B2
Authority
MA
Morocco
Prior art keywords
rheumatoid arthritis
compositions
methods
treating rheumatoid
monotherapy
Prior art date
Application number
MA43465A
Other languages
French (fr)
Other versions
MA43465A1 (en
Inventor
Deborah Bauer
Alexander Boddy
Neil Graham
Yong Lin
Janie Parrino
Rahul Patel
Adelsberg Janet Van
Hoogstraten Hubert Van
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Priority claimed from PCT/US2017/021149 external-priority patent/WO2017155990A1/en
Publication of MA43465A1 publication Critical patent/MA43465A1/en
Publication of MA43465B2 publication Critical patent/MA43465B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne l'utilisation d'un anticorps du récepteur anti-il6 en monothérapie pour le traitement de la polyarthrite rhumatoïde et pour l'amélioration de la fonction physique et de la qualité de vie d'un sujet souffrant de polyarthrite rhumatoïde.The present invention relates to the use of an anti-il6 receptor antibody as monotherapy for the treatment of rheumatoid arthritis and for the improvement of the physical function and quality of life of a subject suffering from rheumatoid arthritis.

MA43465A 2016-05-20 2017-03-07 Compositions and methods for treating rheumatoid arthritis MA43465B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16170664 2016-05-20
PCT/US2017/021149 WO2017155990A1 (en) 2016-03-07 2017-03-07 Compositions and methods for treating rheumatoid arthritis

Publications (2)

Publication Number Publication Date
MA43465A1 MA43465A1 (en) 2019-03-29
MA43465B2 true MA43465B2 (en) 2023-01-31

Family

ID=56101289

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43465A MA43465B2 (en) 2016-05-20 2017-03-07 Compositions and methods for treating rheumatoid arthritis

Country Status (1)

Country Link
MA (1) MA43465B2 (en)

Also Published As

Publication number Publication date
MA43465A1 (en) 2019-03-29

Similar Documents

Publication Publication Date Title
MA49279A (en) ANTIBODY COMPOSITIONS OPTIMIZED FOR THE TREATMENT OF EYE DISORDERS
MA40755B1 (en) Compositions comprising bacterial strains
MA49760B1 (en) Mavacamten for use in the treatment of hypertrophic cardiomyopathy
MA41010A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
EP3642667C0 (en) ORTHOKERATOLOGY CONTACT LENS FOR THE TREATMENT OF MYOPIA
MA53937A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA67726B1 (en) THERAPEUTIC USES OF DEUTERATED LANIFIBRANOR DERIVATIVES
MA43982A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
PH12020551443A1 (en) Use of anti-il-36r antibodies for treatment of inflammatory bowel disease
EP3645039A4 (en) USE OF ANTI-FAM19A5 ANTIBODIES FOR FIBROSIS TREATMENT
MA44334A (en) ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST
MA44594B1 (en) Anti-ctla-4 Antibodies and Methods of Use thereof
PH12020551710A1 (en) Anti-hla-g antibodies and use thereof
MA35180B1 (en) Use of an anti-cd19 maytansinoide immunoconjugate antibody for the treatment of symptoms of B-cell malignancies
MA37946B1 (en) Use of an anti-gm-csf antibody for the treatment of rheumatoid arthritis
MA55218A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
EP3573658A4 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE PSORIASIC RHEUMATISM
EP3630102A4 (en) FORMULATIONS FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER
EP3902826A4 (en) USE OF ANTI-FAM19A5 ANTIBODIES FOR THE TREATMENT OF ATHEROSCLEROSIS
EP3848331A4 (en) DESALINATION SYSTEM CAPABLE OF PRODUCING HYDROGEN
MA44645B1 (en) Combined treatment of an anti-cd20 antibody with a bcl-2 inhibitor and an mdm2 inhibitor
MA47221A1 (en) Monoclonal antibody to pd-l1
EP3994844A4 (en) INTERNET OF THINGS (IoT) SYSTEM FOR WIRING INFRASTRUCTURE
WO2017177024A8 (en) METHODS OF TREATING OCULAR DISORDERS
EP3612214A4 (en) OPTIMIZATION OF ALTERNATIVE ENZYMOTHERAPY FOR THE TREATMENT OF HOMOCYSTINURIA